CLINICAL_TRIALS
trial_result
· 2020-12-09
Clinical Trial Update: Bioequivalence Study of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea on the Face [Phase 3]
Summary
A Phase 3 bioequivalence study evaluating two treatments for inflammatory facial lesions in rosacea has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Padagis LLC | Conditions: Rosacea | Phase 3 | Status: COMPLETED | Results posted: 2020-12-09